Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001262388-25-000008
Filing Date
2025-11-18
Accepted
2025-11-18 16:26:43
Documents
1
Period of Report
2025-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1763501198.html 4  
1 FORM 4 wk-form4_1763501198.xml 4 4778
  Complete submission text file 0001262388-25-000008.txt   6514
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Issuer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 450 LEXINGTON AVENUE, FLOOR 13 NEW YORK NY 10017
Business Address
Sulzberger Gabrielle (Reporting) CIK: 0001262388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06351 | Film No.: 251495115